What is Relay Therapeutics, Inc. Common Stock's Market Cap?

Relay Therapeutics, Inc. Common Stock's Market Cap is $4.2B, based on as-reported figures from SEC (XBRL) filings.

What is Relay Therapeutics, Inc. Common Stock's Enterprise Value?

Relay Therapeutics, Inc. Common Stock's Enterprise Value is $4.1B, based on as-reported figures from SEC (XBRL) filings.

What is Relay Therapeutics, Inc. Common Stock's Price / Sales?

Relay Therapeutics, Inc. Common Stock's Price / Sales is 403.6×, based on as-reported figures from SEC (XBRL) filings.

What is Relay Therapeutics, Inc. Common Stock's EV / Revenue?

Relay Therapeutics, Inc. Common Stock's EV / Revenue is 391.9×, based on as-reported figures from SEC (XBRL) filings.

What is Relay Therapeutics, Inc. Common Stock's EV / EBITDA?

Relay Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Relay Therapeutics, Inc. Common Stock's Revenue (TTM)?

Relay Therapeutics, Inc. Common Stock's Revenue (TTM) is $10.3M, based on as-reported figures from SEC (XBRL) filings.

What is Relay Therapeutics, Inc. Common Stock's Net Income (TTM)?

Relay Therapeutics, Inc. Common Stock's Net Income (TTM) is -$286.0M, based on as-reported figures from SEC (XBRL) filings.

What is Relay Therapeutics, Inc. Common Stock's EBITDA?

Relay Therapeutics, Inc. Common Stock's EBITDA is -$308.2M, based on as-reported figures from SEC (XBRL) filings.

What is Relay Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Relay Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.31, based on as-reported figures from SEC (XBRL) filings.

What is Relay Therapeutics, Inc. Common Stock's EBITDA Margin?

Relay Therapeutics, Inc. Common Stock's EBITDA Margin is -2978.0%, based on as-reported figures from SEC (XBRL) filings.

Relay Therapeutics, Inc. Common Stock (RLAY) Financial Statements

Relay Therapeutics, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00DSS08L8

XNAS · usd

19.06▼ 0.05 (-0.26%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close19.11

Day's Range18.31 – 19.28

52-Week Range3.87 – 21.27

Volume4.5M

Avg Volume2.3M

Share Statistics

Shares Outstanding

Employees192

ExchangeXNAS

Listed2020-07-16

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Relay Therapeutics, Inc. Common Stock (RLAY)

What is Relay Therapeutics, Inc. Common Stock's Market Cap?: Relay Therapeutics, Inc. Common Stock's Market Cap is $4.2B, based on as-reported figures from SEC (XBRL) filings.
What is Relay Therapeutics, Inc. Common Stock's Enterprise Value?: Relay Therapeutics, Inc. Common Stock's Enterprise Value is $4.1B, based on as-reported figures from SEC (XBRL) filings.
What is Relay Therapeutics, Inc. Common Stock's Price / Sales?: Relay Therapeutics, Inc. Common Stock's Price / Sales is 403.6×, based on as-reported figures from SEC (XBRL) filings.
What is Relay Therapeutics, Inc. Common Stock's EV / Revenue?: Relay Therapeutics, Inc. Common Stock's EV / Revenue is 391.9×, based on as-reported figures from SEC (XBRL) filings.
What is Relay Therapeutics, Inc. Common Stock's EV / EBITDA?: Relay Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Relay Therapeutics, Inc. Common Stock's Revenue (TTM)?: Relay Therapeutics, Inc. Common Stock's Revenue (TTM) is $10.3M, based on as-reported figures from SEC (XBRL) filings.
What is Relay Therapeutics, Inc. Common Stock's Net Income (TTM)?: Relay Therapeutics, Inc. Common Stock's Net Income (TTM) is -$286.0M, based on as-reported figures from SEC (XBRL) filings.
What is Relay Therapeutics, Inc. Common Stock's EBITDA?: Relay Therapeutics, Inc. Common Stock's EBITDA is -$308.2M, based on as-reported figures from SEC (XBRL) filings.
What is Relay Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Relay Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.31, based on as-reported figures from SEC (XBRL) filings.
What is Relay Therapeutics, Inc. Common Stock's EBITDA Margin?: Relay Therapeutics, Inc. Common Stock's EBITDA Margin is -2978.0%, based on as-reported figures from SEC (XBRL) filings.